دورية أكاديمية

181P SELECT: A phase II randomized trial evaluating 2 doses of vopratelimab (V) + pimivalimab (P) vs P in TISvopra selected patients (pts)

التفاصيل البيبلوغرافية
العنوان: 181P SELECT: A phase II randomized trial evaluating 2 doses of vopratelimab (V) + pimivalimab (P) vs P in TISvopra selected patients (pts)
المؤلفون: Gumus, M., Sukalinskaya, A., Andric, Z.G., Cheshuk, V., Ciuleanu, T-E., Sezgin Goksu, S., Cil, T., Cicin, I., Bulat, I.V., Ostapenko, Y.V., Penkov, K.D., Hart, C., Lai, M., Chaao, B., Jimenez, J., Sepahi, A., Shi, G., Trott, S., Hooper, E.
المصدر: In Immuno-Oncology and Technology December 2022 16 Supplement 1
قاعدة البيانات: ScienceDirect
الوصف
تدمد:25900188
DOI:10.1016/j.iotech.2022.100293